Leerink Partners Issues Positive Forecast for Intuitive Surgical (NASDAQ:ISRG) Stock Price

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) had its price objective lifted by stock analysts at Leerink Partners from $490.00 to $548.00 in a report released on Monday. Leerink Partners' price objective suggests a potential downside of 4.44% from the stock's current price.

Other equities research analysts have also recently issued reports about the company. Bernstein Bank raised their price target on Intuitive Surgical from $655.00 to $700.00 and gave the company an "overweight" rating in a report on Monday. Royal Bank of Canada boosted their price target on Intuitive Surgical from $611.00 to $641.00 in a report on Monday. The Goldman Sachs Group set a $604.00 price objective on shares of Intuitive Surgical in a report on Friday, October 18th. Jefferies Financial Group upped their target price on shares of Intuitive Surgical from $475.00 to $575.00 in a research report on Monday. Finally, Erste Group Bank upgraded shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a report on Tuesday, November 19th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have issued a buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of $613.10.

Intuitive Surgical Stock Performance

Shares of NASDAQ ISRG traded down $10.57 during midday trading on Monday, reaching $573.48. The stock had a trading volume of 2,439,723 shares, compared to its average volume of 2,025,429. Intuitive Surgical has a 12-month low of $364.17 and a 12-month high of $616.00. The stock has a 50-day moving average of $547.16 and a 200-day moving average of $505.21. The company has a market capitalization of $204.26 billion, a price-to-earnings ratio of 92.20, a price-to-earnings-growth ratio of 5.19 and a beta of 1.39.

Insider Activity

In other news, CFO Jamie Samath sold 108 shares of Intuitive Surgical stock in a transaction on Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total transaction of $58,542.48. Following the completion of the sale, the chief financial officer now directly owns 8,757 shares in the company, valued at approximately $4,746,819.42. This trade represents a 1.22 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Robert Desantis sold 188 shares of the company's stock in a transaction dated Tuesday, October 29th. The stock was sold at an average price of $506.52, for a total transaction of $95,225.76. Following the completion of the transaction, the executive vice president now owns 5,506 shares in the company, valued at approximately $2,788,899.12. The trade was a 3.30 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 42,453 shares of company stock valued at $22,059,506. 0.90% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Intuitive Surgical

Several large investors have recently added to or reduced their stakes in the stock. Bennett Selby Investments LP raised its stake in shares of Intuitive Surgical by 3.9% during the fourth quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider's stock valued at $234,000 after acquiring an additional 17 shares in the last quarter. LVW Advisors LLC raised its position in Intuitive Surgical by 1.3% during the 4th quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider's stock valued at $756,000 after purchasing an additional 19 shares in the last quarter. Wesbanco Bank Inc. grew its position in shares of Intuitive Surgical by 1.6% during the 4th quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider's stock worth $635,000 after buying an additional 19 shares in the last quarter. FSM Wealth Advisors LLC increased its stake in shares of Intuitive Surgical by 3.7% during the fourth quarter. FSM Wealth Advisors LLC now owns 526 shares of the medical equipment provider's stock valued at $275,000 after buying an additional 19 shares during the period. Finally, Journey Strategic Wealth LLC raised its holdings in shares of Intuitive Surgical by 1.9% in the fourth quarter. Journey Strategic Wealth LLC now owns 1,039 shares of the medical equipment provider's stock valued at $542,000 after acquiring an additional 19 shares in the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.